Skip to main content
Home / News and Insights / News / Bircham Dyson Bell advises ImmuPharma PLC on its £10 million fundraising
25 January 2018

Bircham Dyson Bell advises ImmuPharma PLC on its £10 million fundraising

Bircham Dyson Bell acted for ImmuPharma PLC, the AIM-listed specialist drug discovery and development company, in relation to its fundraising, which raised £10 million by way of a share subscription and placing with new and existing shareholders.

The transaction was led by corporate partner Philip Lamb and senior associate Tessa Trevelyan Thomas.

Philip Lamb comments:

‘We are delighted by the successful outcome of this fundraising at an exciting stage of the company’s development, and to be continuing our long-standing relationship with the company dating back to before it floated in 2006.’

Related Articles

Our Offices

London
50 Broadway, London
SW1H 0BL

Cambridge
50/60 Station Road
Cambridge
CB1 2JH

Reading
The Anchorage, 34 Bridge Street
Reading RG1 2LU

Southampton
Grosvenor House, Grosvenor Square
Southampton SO15 2BE

 

Reading
The Anchorage, 34 Bridge Street
Reading RG1 2LU

Southampton
Grosvenor House, Grosvenor Square
Southampton SO15 2BE

Follow us

  • Pay my invoice
  • Lexcel
  • CYBER ESSENTIALS PLUS

© BDB Pitmans 2020. 50 Broadway, London, SW1H 0BL - T +44 (0)345 222 9222